# Abbott Laboratories (ABT) — Q2-2019 Earnings Results

**Report date:** 2019-07-17 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q2-2019

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Up 3.13%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.82 | N/A | +0.95% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of maintaining strong product offerings.

**Key quotes:**

> Management highlighted strong performance in key product lines.

> They noted ongoing investments in innovation to drive future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs' earnings report shows a positive surprise on EPS, which contributed to a 3.13% increase in stock price. The company’s management is optimistic about future growth driven by strong product performance and innovation. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q2-2019_